Future of Cell Therapy in the Regenerative Medicine Market

Future of Cell Therapy in the Regenerative Medicine Market

Combination Therapies and Advanced Manufacturing Techniques are the New Criteria Shaping the $4 Billion Market

RELEASE DATE
25-May-2016
REGION
North America
Research Code: P8D5-01-00-00-00
SKU: HC02642-NA-MR_18603

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02642-NA-MR_18603

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Research Overview
This Frost & Sullivan research service analyses the current trends, forecasts and the external factors influencing the global cell therapy market. It also studies top participants in the market, disruptive pipeline products, and the opportunities in combination therapy. In addition, it provides a detailed commercialization analysis of research and development (R&D), manufacturing, and funding considerations.

Table of Contents

Main Focus Regions

Overall Regenerative Market

Base Year

Study Period

Key Takeaways— how is this Market Important to You?

Executive Summary—Market Snapshot

Key 2016 Predictions—Cell Therapy Market

Big Market Themes for Cell Therapy

  • Established Cell Therapy Companies
  • Small- to Medium-sized Companies
  • Pharmaceutical Companies
  • Support Industry Expansion
  • Manufacturing Facilities

A Vibrant Ecosystem - Total Cell Therapy Market: Ecosystem, Global, 2015

  • Restraints
  • Drivers

Paradigm Shift to Chronic Disease Therapies

Regional Highlights and Developments

  • MSCs Dominate the Market
  • Opportunities Within the Ecosystem
  • Market Moving to Focus on Key Need Areas
  • Funding Splurge
  • Companies Ramping up R&D
  • Increasing Collaborative Activities
  • Regional Regulations are Changing to Accommodate Cell Therapy
  • Disruptive Therapies

Game-changing Companies

Private Investors Pour in Significant Funds

Key Methodology

Next Wave of Cell Therapy

Potential Launch Dates

Overall Breakdown of Cell Therapy Market

Competitive Landscape of Marketed Products

Cell Therapy—Competitive Landscape of Products in Development

Potential Game-changing Therapies

Competitive Overview of Established Companies

Cell Therapy—Cardiovascular

Cell Therapy—Immunology

Cell Therapy—Oncology

Cell Therapy—Musculoskeletal

Cell Therapy—Dermatology

Cell Therapy—Neurology

Cell-gene Therapies and How They Work

Key Product Example to Watch For

Disruptive Technologies and Advances in this Field

Opportunities in this Market

Overall Environmental Impact Factors

Ongoing Stem Cell Clinical Trials by Indication

Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials

Commercial Considerations for Selections of Cell Type

Autologous versus Allogeneic Cell Products

Manufacturing Models that Work

Manufacturing Models that Failed

Funding Key Points – Trends

Cell Therapy Deals from 2010 to 2015

Funding Environment—Where are the Funds Coming From?

Merger, Acquisition, and Partnership Assessment

Cell Therapy Market—Funding Scenario

Key 2016 Predictions—Cell Therapy Market

Key Conclusions and Future Outlook

Growth Opportunities in Top Segments

Pitfalls to Avoid

Cell Therapy Market—Major Ongoing/Recently Completed Clinical Trials

List of Figures
  • 1. Total Cell Therapy Market: Key Market Metrics, Global, 2015
  • 2. Total Cell Therapy Market: Regional Market Share, Global, 2015
  • 3. Total Cell Therapy Market: Ecosystem, Global, 2015
  • 4. Total Cell Therapy Market: Regional Highlights, Global, 2015
  • 5. Cell Therapy Market: Examples of Key Companies, Global, 2015
  • 6. Cell Therapy Market: Key Methodology, Global, 2015
  • 7. Cell Therapy Market: Potential Market Launches, Global, 2015–2030
  • 8. Cell Therapy Market: Overall Pipeline Breakdown, Global, 2015
  • 9. Cell Therapy Market: Overall Breakdown by Promising Indications, Global, 2015
  • 10. Cell Therapy Market: Potential Market Launches, Global, 2016–2019
  • 11. Cell Therapy Market: Potential Market Launches, Global, 2016–2019
  • 12. Cell Therapy Market: Apligraf Product Dashboard, Global, 2015
  • 13. Cell Therapy Market: GINTUIT Product Dashboard, Global, 2015
  • 14. Cell Therapy Market: Grafix Product Dashboard, Global, 2015
  • 15. Cell Therapy Market: Dermagraft Product Dashboard, Global, 2015
  • 16. Cell Therapy Market: Osteocel Plus Product Dashboard, Global, 2015
  • 17. Cell Therapy Market: ReCell Spray-on Skin Product Dashboard, Global, 2015
  • 18. Cell Therapy Market: Trinity Evolution Product Dashboard, Global, 2015
  • 19. Cell Therapy Market: BioDfactor Product Dashboard, Global, 2015
  • 20. Cell Therapy Market: BioDfence Product Dashboard, Global, 2015
  • 21. Cell Therapy Market: Percent Breakdown of Commercially Available Products by Therapeutic Area, Global, 2015
  • 22. Cardiovascular Segment: Key Product Launch* Timeline, Cell Therapy, Global, 2015–2020
  • 23. Key Trends in Cardiovascular Cell Therapy, Global, 2015
  • 24. Cell Therapy Market: C-Cure Product Dashboard, Global, 2015
  • 25. Cell Therapy Market: Heartcel Product Dashboard, Global, 2015
  • 26. Cell Therapy Market: MyoCell Product Dashboard, Global, 2015
  • 27. Immunology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020
  • 28. Key Trends in Immunology Cell Therapy, Global, 2015
  • 29. Cell Therapy Market: Prochymal, Product Dashboard, Global, 2015
  • 30. Cell Therapy Market: Cx601, Product Dashboard, Global, 2015
  • 31. Cell Therapy Market: MPC-100-IV Product Dashboard, Global, 2015
  • 32. Oncology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020
  • 33. Key Trends in Oncology Cell Therapy, Global, 2015
  • 34. Cell Therapy Market: NiCord, Product Dashboard, Global, 2015
  • 35. Cell Therapy Market: StemEx Product Dashboard, Global, 2015
  • 36. Cell Therapy Market: ImmuniCell Product Dashboard, Global, 2015
  • 37. Musculoskeletal Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020
  • 38. Key Trends in Musculoskeletal Cell Therapy, Global, 2015
  • 39. Cell Therapy Market: NeoCart Product Dashboard, Global, 2015
  • 40. Cell Therapy Market: NOVOCART 3D Product Dashboard, Global, 2015
  • 41. Dermatology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020
  • 42. Key Trends in Dermatology Cell Therapy, Global, 2015
  • 43. Cell Therapy Market: ALLO-ASC-DFU, Product Dashboard, Global, 2015
  • 44. Neurology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020
  • 45. Key Trends in Neurological Cell Therapy, Global, 2015
  • 46. Cell Therapy Market: MPC-06-ID Product Dashboard, Global, 2015
  • 47. Cell Therapy Market: CTL019, Product Dashboard, Global, 2015
  • 48. Cell Therapy Market: JCAR015 Product Dashboard, Global, 2015
  • 49. Cell Therapy Segment: KTE-C19 Product Dashboard, Global, 2015
  • 50. Cell Therapy Market: Game-changing Strategies, Global, 2015
  • 51. Cell Therapy Market: Environmental Impact Factors, Global, 2015
  • 52. Cell Types to Consider: Cord/Placental Blood
  • 53. Cell Types to Consider: Bone Marrow
  • 54. Cell Types to Consider: Peripheral Blood
  • 55. Cell Types to Consider: Adipose Tissue
  • 56. Cell Therapy Market: Clinical Trial Process, Global
  • 57. Map: Snapshot of Regulatory Policies for Stem Cell Therapy
  • 58. Cell Therapy Market: Regions with Best Practices, Canada, 2015
  • 59. Cell Therapy Market: Japanese Regulatory Process, Japan, 2015
  • 60. Cell Therapy Market: Manufacturing for ChondroCelect (Autologous Product), Europe, 2015
  • 61. Cell Therapy Market: Manufacturing for Prochymal (Allogeneic Product), Europe and Canada, 2015
  • 62. Cell Therapy Market: Manufacturing for Provenge (Immunotherapy), US, 2015
  • 63. Cell Therapy Market: Key Trends in the Funding Environment, Global, 2015
  • 64. Cell Therapy Market: Market Outlook, Global, 2012–2016
  • 65. Cell Therapy Market: Funding Scenario, Global, 2012–2015
  • 66. Cell Therapy Market: Key Predictions, Global, 2016
  • 67. Cell Therapy Market: Key Conclusions and Future Outlook, Global, 2015–2020
  • 68. Cell Therapy Market: Growth Opportunities, Global, 2016–2020
  • 69. Cell Therapy Market: Ongoing/Recently Completed Clinical Trials Timelines and Design, Global, 2010–2016
List of Charts
  • 1. Total Cell Therapy Market: Scenario Analysis, Global, 2015–2020
  • 2. Cell Therapy Market: Percent Breakdown by Marketed Products, Global, 2015
  • 3. Cell Therapy Market: Percent Breakdown by Pipeline Products, Global, 2015
  • 4. Cell Therapy Market: Funding Environment, Global, 2014–2015
  • 5. Cell Therapy Market: Outstanding Marketed Products by Therapeutic Area, Global, 2015
  • 6. Cell Therapy Market: Products in Development by Therapeutic Area, Global, 2015
  • 7. Cell Therapy Market: Products in Development by Therapeutic Area, Global, 2015
  • 8. Cell Therapy Market: Marketed Products, Global, 2015 (Cardiovascular)
  • 9. Cell Therapy Market: Marketed Products, Global, 2015 (Immunology)
  • 10. Cell Therapy Market: Marketed Products, Global, 2015 (Oncology)
  • 11. Cell Therapy Market: Marketed Products, Global, 2015 (Musculoskeletal)
  • 12. Cell Therapy Market: Marketed Products, Global, 2015 (Dermatology)
  • 13. Cell Therapy Market: Ongoing Stem Cell Studies by Indication, Global, 2015
  • 14. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Neurology - Type of Cell Source
  • 15. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Neurology - Cell Type
  • 16. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Oncology - Type of Cell Source
  • 17. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Oncology - Cell Type
  • 18. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Autoimmune - Type of Cell Source
  • 19. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Autoimmune - Cell Type
  • 20. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Dermatology - Type of Cell Source
  • 21. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Dermatology - Cell Type
  • 22. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Cardiovascular - Type of Cell Source
  • 23. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Cardiovascular - Cell Type
  • 24. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Musculoskeletal - Type of Cell Source
  • 25. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Musculoskeletal - Cell Type
  • 26. Cell Therapy Market: Total vs. Ongoing Autologous and Allogeneic Clinical Trials, Global, 2015
  • 27. Cell Therapy Market: Number of Deals, Global, 2010–2015
  • 28. Cell Therapy Market: Overall Deals by Indication, Global, 2015
  • 29. Cell Therapy Market: Funding Environment, Global, 2014–2015
Related Research
Research Overview This Frost & Sullivan research service analyses the current trends, forecasts and the external factors influencing the global cell therapy market. It also studies top participants in the market, disruptive pipeline products, and the opportunities in combination therapy. In addition, it provides a detailed commercialization analysis of research and development (R&D), manufacturing, and funding considerations.
More Information
No Index No
Podcast No
Table of Contents | Scope and Segmentation~ || Main Focus Regions~ || Overall Regenerative Market~ || Base Year~ || Study Period~ | Executive Summary~ || Key Takeaways— how is this Market Important to You?~ ||| Established Cell Therapy Companies~ ||| Small- to Medium-sized Companies~ ||| Pharmaceutical Companies~ ||| Support Industry Expansion~ ||| Manufacturing Facilities~ || Executive Summary—Market Snapshot~ ||| Restraints~ |||| Lack of early-stage funding curtails innovative products from reaching the market.~ |||| Inherent variability in cells and cultures make scaling-up a challenge.~ |||| Undefined federal regulations for cell production and testing.~ |||| High patient treatment cost.~ |||| Lack of clear healthcare reimbursement pathways.~ ||| Drivers~ |||| Growing aging populations with higher of disease prevalence calls for alternative treatments.~ |||| High cost of socialized medicine in many countries.~ |||| Increasing clinical evidence of efficacy with “curative” potential, especially with cell-gene therapies.~ |||| Cell therapy is increasingly being adopted by physicians.~ |||| Both public and private funding is becoming more available for research and development (R&D), early-, and late-stage clinical trials.~ |||| Pharmaceutical companies are becoming “interested”.~ || Key 2016 Predictions—Cell Therapy Market~ || Big Market Themes for Cell Therapy~ ||| MSCs Dominate the Market~ ||| Opportunities Within the Ecosystem~ ||| Market Moving to Focus on Key Need Areas~ ||| Funding Splurge~ ||| Companies Ramping up R&D~ ||| Increasing Collaborative Activities~ ||| Regional Regulations are Changing to Accommodate Cell Therapy~ ||| Disruptive Therapies~ || A Vibrant Ecosystem - Total Cell Therapy Market: Ecosystem, Global, 2015~ || Paradigm Shift to Chronic Disease Therapies~ || Regional Highlights and Developments~ || Game-changing Companies~ || Private Investors Pour in Significant Funds~ | Disruptive Pipeline Analysis~ || Key Methodology~ || Next Wave of Cell Therapy~ || Potential Launch Dates~ || Overall Breakdown of Cell Therapy Market~ || Competitive Landscape of Marketed Products~ || Cell Therapy—Competitive Landscape of Products in Development~ || Potential Game-changing Therapies~ | Product Dashboard of Leading Commercial Cell Therapy Products~ || Product Dashboard~ ||| Apligraf (Organogenesis)~ ||| GINTUIT (Organogenesis)~ ||| Grafix (Osiris Therapeutics)~ ||| Dermagraft (Shire)~ ||| Osteocel Plus (NuVasive)~ ||| ReCell Spray-on Skin (Avita Medical)~ ||| Trinity Evolution (Orthofix)~ ||| BioDfactor (BioD, LLC)~ ||| BioDfence (BioD, LLC)~ | Key Companies and Products to Watch by Indication~ || Competitive Overview of Established Companies~ ||| Avita~ ||| Mesoblast~ ||| Pharmicell~ ||| Shire~ ||| Others~ || Cell Therapy—Cardiovascular~ ||| C-Cure (Celyad)~ ||| Heartcel (Cell Therapy LTD)~ ||| MyoCell (BioHeart)~ || Cell Therapy—Immunology~ ||| Prochymal (Mesoblast)~ ||| Cx601 (TiGenix)~ ||| MPC-100-IV (Remestemcel-L; Mesoblast)~ || Cell Therapy—Oncology~ ||| NiCord (Gamida Cell)~ ||| StemEx (Gamida Cell)~ ||| ImmuniCell (TC BioPharm)~ || Cell Therapy—Musculoskeletal~ ||| NeoCart (Histogenics)~ ||| NOVOCART 3D (Aesculap/B. Braun)~ || Cell Therapy—Dermatology~ ||| ALLO-ASC-DFU (Anterogen)~ || Cell Therapy—Neurology~ ||| MPC-06-ID (Mesoblast)~ | Opportunities in Combination Therapies~ || Cell-gene Therapies and How They Work~ || Key Product Example to Watch For~ ||| CTL019 (Novartis)~ ||| JCAR015 (Juno Therapeutics)~ ||| KTE-C19 (Kite Pharmaceutical)~ || Disruptive Technologies and Advances in this Field~ ||| Lentivirus~ ||| CRISPR~ | Commercialization Analysis~ || Opportunities in this Market~ || Overall Environmental Impact Factors~ | Commercialization Analysis—R&D Considerations~ || Ongoing Stem Cell Clinical Trials by Indication~ || Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials~ || Commercial Considerations for Selections of Cell Type~ | Commercialization Analysis—Regulatory Considerations (Despite popular belief, Frost & Sullivan’s pipeline data indicates an equal numbers of allogeneic and autologous clinical trials.)~ || Cell Therapy Regulatory Process~ || A Snapshot of Regulatory Policies for Stem Cell Therapy~ ||| Canada’s Unique Infrastructure—Center of Excellence~ ||| Japan’s Unique Regulatory Infrastructure~ | Commercializing Analysis—Manufacturing Considerations (The market is shifting away from autologous therapies towards allogeneic cell therapies.)~ || Autologous versus Allogeneic Cell Products~ || Manufacturing Models that Work~ ||| TiGenix~ ||| Mesoblast~ || Manufacturing Models that Failed~ ||| Dendreon Therapeutics~ | Commercialization Analysis—Funding Considerations (Pushing Products Past the “Valley of Death”)~ || Funding Key Points – Trends~ ||| Venture Investments Rapidly Growing~ ||| Hope for Early Stage Products~ ||| Stagnation of New Start-ups~ ||| Short Venture Financing Life Cycle~ ||| Difficult to Raise Capital for New Deals~ || Cell Therapy Deals from 2010 to 2015~ || Funding Environment—Where are the Funds Coming From?~ || Merger, Acquisition, and Partnership Assessment~ ||| Healios and Athersys (ATHX)~ ||| NeoStem and Invetech~ ||| Takeda and NsGene~ ||| SQZ Biotech and Roche~ ||| CTM CRC, CCRM, and Cell Therapy Catapult~ ||| Stem Cell Therapeutics Corp./ Trillium Therapeutics Inc.~ ||| BioTime Inc./Geron Corporation~ ||| Mesoblast/Osiris Therapeutics~ ||| Living Cell Technologies Limited (LCT)/ Otsuka Pharmaceutical Factory Inc. (OPF)~ ||| Smith & Nephew plc/ Healthpoint Biotherapeutics~ ||| AxoGen Inc./PDL BioPharma Inc.~ ||| Kensey Nash/Royal DSM~ ||| Shire Plc/Pervasis Therapeutics~ ||| Cytomedix Inc./ Aldagen~ || Cell Therapy Market—Funding Scenario~ ||| Cytori Therapeutics Inc.~ ||| bluebird bio~ ||| Histogenics Corporation~ ||| Fibrocell Science Inc.~ ||| Others~ | Conclusion and Take Home Points~ || Key 2016 Predictions—Cell Therapy Market~ || Key Conclusions and Future Outlook~ || Growth Opportunities in Top Segments~ ||| Cell Therapy Overall~ ||| Stem Cell~ ||| Immunotherapy~ ||| Cell-Gene~ || Pitfalls to Avoid~ ||| Network & Logistics~ ||| Efficient Technology~ ||| Funding Concerns~ ||| Regulatory Processes~ ||| Business Model Inadequacies~ | Legal Disclaimer~ | Appendix—Cell Therapy Major Clinical Trial Milestones~ || Cell Therapy Market—Major Ongoing/Recently Completed Clinical Trials~
List of Charts and Figures 1. Total Cell Therapy Market: Key Market Metrics, Global, 2015~ 2. Total Cell Therapy Market: Regional Market Share, Global, 2015~ 3. Total Cell Therapy Market: Ecosystem, Global, 2015~ 4. Total Cell Therapy Market: Regional Highlights, Global, 2015~ 5. Cell Therapy Market: Examples of Key Companies, Global, 2015~ 6. Cell Therapy Market: Key Methodology, Global, 2015~ 7. Cell Therapy Market: Potential Market Launches, Global, 2015–2030~ 8. Cell Therapy Market: Overall Pipeline Breakdown, Global, 2015~ 9. Cell Therapy Market: Overall Breakdown by Promising Indications, Global, 2015~ 10. Cell Therapy Market: Potential Market Launches, Global, 2016–2019~ 11. Cell Therapy Market: Potential Market Launches, Global, 2016–2019~ 12. Cell Therapy Market: Apligraf Product Dashboard, Global, 2015~ 13. Cell Therapy Market: GINTUIT Product Dashboard, Global, 2015~ 14. Cell Therapy Market: Grafix Product Dashboard, Global, 2015~ 15. Cell Therapy Market: Dermagraft Product Dashboard, Global, 2015~ 16. Cell Therapy Market: Osteocel Plus Product Dashboard, Global, 2015~ 17. Cell Therapy Market: ReCell Spray-on Skin Product Dashboard, Global, 2015~ 18. Cell Therapy Market: Trinity Evolution Product Dashboard, Global, 2015~ 19. Cell Therapy Market: BioDfactor Product Dashboard, Global, 2015~ 20. Cell Therapy Market: BioDfence Product Dashboard, Global, 2015~ 21. Cell Therapy Market: Percent Breakdown of Commercially Available Products by Therapeutic Area, Global, 2015~ 22. Cardiovascular Segment: Key Product Launch* Timeline, Cell Therapy, Global, 2015–2020~ 23. Key Trends in Cardiovascular Cell Therapy, Global, 2015~ 24. Cell Therapy Market: C-Cure Product Dashboard, Global, 2015~ 25. Cell Therapy Market: Heartcel Product Dashboard, Global, 2015~ 26. Cell Therapy Market: MyoCell Product Dashboard, Global, 2015~ 27. Immunology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020~ 28. Key Trends in Immunology Cell Therapy, Global, 2015~ 29. Cell Therapy Market: Prochymal, Product Dashboard, Global, 2015~ 30. Cell Therapy Market: Cx601, Product Dashboard, Global, 2015~ 31. Cell Therapy Market: MPC-100-IV Product Dashboard, Global, 2015~ 32. Oncology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020~ 33. Key Trends in Oncology Cell Therapy, Global, 2015~ 34. Cell Therapy Market: NiCord, Product Dashboard, Global, 2015~ 35. Cell Therapy Market: StemEx Product Dashboard, Global, 2015~ 36. Cell Therapy Market: ImmuniCell Product Dashboard, Global, 2015~ 37. Musculoskeletal Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020~ 38. Key Trends in Musculoskeletal Cell Therapy, Global, 2015~ 39. Cell Therapy Market: NeoCart Product Dashboard, Global, 2015~ 40. Cell Therapy Market: NOVOCART 3D Product Dashboard, Global, 2015~ 41. Dermatology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020~ 42. Key Trends in Dermatology Cell Therapy, Global, 2015~ 43. Cell Therapy Market: ALLO-ASC-DFU, Product Dashboard, Global, 2015~ 44. Neurology Segment: Key Product Launch Timeline, Cell Therapy, Global, 2015–2020~ 45. Key Trends in Neurological Cell Therapy, Global, 2015~ 46. Cell Therapy Market: MPC-06-ID Product Dashboard, Global, 2015~ 47. Cell Therapy Market: CTL019, Product Dashboard, Global, 2015~ 48. Cell Therapy Market: JCAR015 Product Dashboard, Global, 2015~ 49. Cell Therapy Segment: KTE-C19 Product Dashboard, Global, 2015~ 50. Cell Therapy Market: Game-changing Strategies, Global, 2015~ 51. Cell Therapy Market: Environmental Impact Factors, Global, 2015~ 52. Cell Types to Consider: Cord/Placental Blood~ 53. Cell Types to Consider: Bone Marrow~ 54. Cell Types to Consider: Peripheral Blood~ 55. Cell Types to Consider: Adipose Tissue~ 56. Cell Therapy Market: Clinical Trial Process, Global~ 57. Map: Snapshot of Regulatory Policies for Stem Cell Therapy~ 58. Cell Therapy Market: Regions with Best Practices, Canada, 2015~ 59. Cell Therapy Market: Japanese Regulatory Process, Japan, 2015~ 60. Cell Therapy Market: Manufacturing for ChondroCelect (Autologous Product), Europe, 2015~ 61. Cell Therapy Market: Manufacturing for Prochymal (Allogeneic Product), Europe and Canada, 2015~ 62. Cell Therapy Market: Manufacturing for Provenge (Immunotherapy), US, 2015~ 63. Cell Therapy Market: Key Trends in the Funding Environment, Global, 2015~ 64. Cell Therapy Market: Market Outlook, Global, 2012–2016~ 65. Cell Therapy Market: Funding Scenario, Global, 2012–2015~ 66. Cell Therapy Market: Key Predictions, Global, 2016~ 67. Cell Therapy Market: Key Conclusions and Future Outlook, Global, 2015–2020~ 68. Cell Therapy Market: Growth Opportunities, Global, 2016–2020~ 69. Cell Therapy Market: Ongoing/Recently Completed Clinical Trials Timelines and Design, Global, 2010–2016~| 1. Total Cell Therapy Market: Scenario Analysis, Global, 2015–2020~ 2. Cell Therapy Market: Percent Breakdown by Marketed Products, Global, 2015~ 3. Cell Therapy Market: Percent Breakdown by Pipeline Products, Global, 2015~ 4. Cell Therapy Market: Funding Environment, Global, 2014–2015~ 5. Cell Therapy Market: Outstanding Marketed Products by Therapeutic Area, Global, 2015~ 6. Cell Therapy Market: Products in Development by Therapeutic Area, Global, 2015~ 7. Cell Therapy Market: Products in Development by Therapeutic Area, Global, 2015~ 8. Cell Therapy Market: Marketed Products, Global, 2015 (Cardiovascular)~ 9. Cell Therapy Market: Marketed Products, Global, 2015 (Immunology)~ 10. Cell Therapy Market: Marketed Products, Global, 2015 (Oncology)~ 11. Cell Therapy Market: Marketed Products, Global, 2015 (Musculoskeletal)~ 12. Cell Therapy Market: Marketed Products, Global, 2015 (Dermatology)~ 13. Cell Therapy Market: Ongoing Stem Cell Studies by Indication, Global, 2015~ 14. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Neurology - Type of Cell Source~ 15. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Neurology - Cell Type~ 16. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Oncology - Type of Cell Source~ 17. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Oncology - Cell Type~ 18. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Autoimmune - Type of Cell Source~ 19. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Autoimmune - Cell Type~ 20. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Dermatology - Type of Cell Source~ 21. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Dermatology - Cell Type~ 22. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Cardiovascular - Type of Cell Source ~ 23. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Cardiovascular - Cell Type~ 24. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Musculoskeletal - Type of Cell Source~ 25. Stem Cell Sources and Stem Cells Used in Pipeline Clinical Trials: Musculoskeletal - Cell Type~ 26. Cell Therapy Market: Total vs. Ongoing Autologous and Allogeneic Clinical Trials, Global, 2015~ 27. Cell Therapy Market: Number of Deals, Global, 2010–2015~ 28. Cell Therapy Market: Overall Deals by Indication, Global, 2015~ 29. Cell Therapy Market: Funding Environment, Global, 2014–2015~
Lightbox Content World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019
Author Aish Vivekanadan
Industries Healthcare
WIP Number P8D5-01-00-00-00
Is Prebook No